Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for AUTL

Stock Name	Autolus Therapeutics Ltd
Ticker	AUTL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US05280R1005
LEI	549300C0KZP8EYROLL02

Show aggregate AUTL holdings

News associated with AUTL

Analysts Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) PT at $9.12: Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) have received an average rating of “Buy” from the five analysts that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average twelve-month price target among brokers that have updated their coverage […] - 2025-09-15 05:04:54
Brokerages Set Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Price Target at $9.12: Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) has been given an average recommendation of “Buy” by the five brokerages that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock […] - 2025-08-19 02:16:53
Autolus Therapeutics (NASDAQ:AUTL) Trading Down 3.5% Following Analyst Downgrade: Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Get Free Report) fell 3.5% during trading on Wednesday after Wells Fargo & Company lowered their price target on the stock from $6.00 to $5.00. Wells Fargo & Company currently has an overweight rating on the stock. Autolus Therapeutics traded as low as $2.02 and last […] - 2025-08-15 02:52:49
Alps Advisors Inc. Sells 15,481 Shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL): Alps Advisors Inc. reduced its stake in shares of Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 7.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 199,709 shares of the company’s stock after selling 15,481 shares during the quarter. Alps Advisors […] - 2025-07-18 04:50:54
Vontobel Holding Ltd. Trims Stock Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL): Vontobel Holding Ltd. decreased its position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 5.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 138,783 shares of the company’s stock after selling 8,636 shares during the period. Vontobel Holding Ltd.’s […] - 2025-07-09 05:04:55
Exchange Traded Concepts LLC Has $108,000 Stake in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL): Exchange Traded Concepts LLC grew its holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL – Free Report) by 67.2% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 69,993 shares of the company’s stock after acquiring an additional 28,127 shares during the period. Exchange Traded Concepts LLC’s holdings in Autolus Therapeutics were worth $108,000 […] - 2025-06-25 04:57:00
Two Sigma Advisers LP Acquires 15,400 Shares of Autolus Therapeutics plc (NASDAQ:AUTL): Two Sigma Advisers LP grew its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 4.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 333,400 shares of the company’s stock after acquiring an additional 15,400 shares during the period. Two Sigma […] - 2025-06-03 05:00:53
OMERS ADMINISTRATION Corp Invests $85,000 in Autolus Therapeutics plc (NASDAQ:AUTL): OMERS ADMINISTRATION Corp bought a new position in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 36,300 shares of the company’s stock, valued at approximately $85,000. A number of other […] - 2025-05-21 05:26:48
Brokerages Set Autolus Therapeutics plc (NASDAQ:AUTL) Price Target at $9.32: Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have updated their coverage on […] - 2025-05-13 02:14:55
Renaissance Technologies LLC Purchases 368,071 Shares of Autolus Therapeutics plc (NASDAQ:AUTL): Renaissance Technologies LLC lifted its holdings in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 146.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 618,942 shares of the company’s stock after purchasing an additional 368,071 shares during the period. Renaissance Technologies LLC’s holdings in Autolus Therapeutics were worth $1,455,000 as of its most recent […] - 2025-04-29 04:44:58
Autolus Therapeutics (NASDAQ:AUTL) Given New $10.00 Price Target at Truist Financial: Autolus Therapeutics (NASDAQ:AUTL – Free Report) had its price objective trimmed by Truist Financial from $11.00 to $10.00 in a report published on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and […] - 2025-04-02 04:14:47
Autolus Therapeutics plc (NASDAQ:AUTL) Receives Average Rating of “Buy” from Analysts: Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued ratings on the stock in the […] - 2025-03-26 03:53:00
Daiwa Securities Group Inc. Has $56,000 Stock Position in Autolus Therapeutics plc (NASDAQ:AUTL): Daiwa Securities Group Inc. grew its stake in Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 55.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 23,743 shares of the company’s stock after purchasing an additional 8,479 shares during the quarter. Daiwa […] - 2025-03-18 05:42:52
Autolus Therapeutics plc (NASDAQ:AUTL) Shares Bought by Handelsbanken Fonder AB: Handelsbanken Fonder AB boosted its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL – Free Report) by 30.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,300 shares of the company’s stock after buying an additional 17,300 shares during […] - 2025-03-04 06:46:54

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) AUTL holdings

Date	Number of AUTL Shares Held	Base Market Value of AUTL Shares	Local Market Value of AUTL Shares	Change in AUTL Shares Held	Change in AUTL Base Value	Current Price per AUTL Share Held	Previous Price per AUTL Share Held
2025-12-15 (Monday)	160,660	USD 260,269	USD 260,269
2025-12-12 (Friday)	159,904	USD 257,445	USD 257,445	0	USD 3,198	USD 1.61	USD 1.59
2025-12-11 (Thursday)	159,904	USD 254,247	USD 254,247	756	USD 10,751	USD 1.59	USD 1.53
2025-12-10 (Wednesday)	159,148	USD 243,496	USD 243,496	0	USD 6,365	USD 1.53	USD 1.49
2025-12-09 (Tuesday)	159,148	USD 237,131	USD 237,131	0	USD -15,914	USD 1.49	USD 1.59
2025-12-08 (Monday)	159,148	USD 253,045	USD 253,045	0	USD 6,366	USD 1.59	USD 1.55
2025-12-05 (Friday)	159,148	USD 246,679	USD 246,679	0	USD -3,183	USD 1.55	USD 1.57
2025-12-04 (Thursday)	159,148	USD 249,862	USD 249,862	7,460	USD 25,364	USD 1.57	USD 1.48
2025-12-03 (Wednesday)	151,688	USD 224,498	USD 224,498	0	USD 21,236	USD 1.48	USD 1.34
2025-12-02 (Tuesday)	151,688	USD 203,262	USD 203,262	5,640	USD 1,716	USD 1.34	USD 1.38
2025-12-01 (Monday)	146,048	USD 201,546	USD 201,546	0	USD -4,382	USD 1.38	USD 1.41
2025-11-28 (Friday)	146,048	USD 205,928	USD 205,928	376	USD 6,357	USD 1.41	USD 1.37

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of AUTL by Blackrock for IE00BDZVHG35

Show aggregate share trades of AUTL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-11 BUY 756 1.605 1.535 1.542 USD 1,166 2.01
2025-12-04 BUY 7,460 1.606 1.460 1.475 USD 11,001 2.02
2025-12-02 BUY 5,640 1.400 1.310 1.319 USD 7,439 2.03
2025-11-28 BUY 376 1.440 1.350 1.359 USD 511 2.04
2025-11-26 BUY 1,128 1.400 1.320 1.328 USD 1,498 2.04
2025-11-26 BUY 1,128 1.400 1.320 1.328 USD 1,498 2.04
2025-11-25 BUY 1,880 1.490 1.310 1.328 USD 2,497 2.05
2025-11-24 BUY 376 1.260 1.215 1.220 USD 459 2.05
2025-11-20 SELL -1,496 1.342 1.230 1.241 USD -1,857 2.06 Profit of 1,223 on sale
2025-11-19 BUY 373 1.335 1.250 1.259 USD 469 2.06
2025-11-18 BUY 2,232 1.320 1.280 1.284 USD 2,866 2.07
2025-11-17 BUY 744 1.360 1.300 1.306 USD 972 2.07
2025-11-14 BUY 373 1.400 1.245 1.261 USD 470 2.07
2025-11-12 BUY 371 1.385 1.230 1.246 USD 462 2.08
2025-11-10 BUY 370 1.400 1.320 1.328 USD 491 2.09
2025-11-06 BUY 370 1.390 1.340 1.345 USD 498 2.10
2025-11-04 BUY 370 1.535 1.400 1.413 USD 523 2.11
2025-10-30 BUY 1,860 1.545 1.475 1.482 USD 2,757 2.12
2025-10-29 BUY 742 1.460 1.560 1.550 USD 1,150 2.12
2025-10-22 SELL -1,464 1.550 1.645 1.635 USD -2,394 2.14 Profit of 731 on sale
2025-10-20 BUY 732 1.700 1.720 1.718 USD 1,258 2.14
2025-10-17 BUY 1,825 1.620 1.673 1.668 USD 3,044 2.14
2025-10-15 BUY 2,888 1.720 1.755 1.751 USD 5,058 2.15
2025-10-03 BUY 2,604 1.610 1.640 1.637 USD 4,263 2.15
2025-10-02 BUY 371 1.610 1.699 1.690 USD 627 2.16
2025-09-30 BUY 742 1.630 1.650 1.648 USD 1,223 2.16
2025-09-26 BUY 744 1.560 1.590 1.587 USD 1,181 2.17
2025-09-25 BUY 744 1.500 1.580 1.572 USD 1,170 2.17
2025-09-18 BUY 372 1.360 1.370 1.369 USD 509 2.18
2025-09-17 BUY 1,119 1.270 1.350 1.342 USD 1,502 2.18
2025-07-17 SELL -724 2.420 2.469 2.464 USD -1,784 2.19 Loss of -202 on sale
2025-07-11 SELL -2,920 2.470 2.520 2.515 USD -7,344 2.18 Loss of -988 on sale
2025-07-02 BUY 20,075 2.350 2.440 2.431 USD 48,802 2.17
2025-06-25 BUY 728 2.320 2.320 2.320 USD 1,689 2.17
2025-06-11 BUY 738 2.240 2.370 2.357 USD 1,739 2.17
2025-06-10 BUY 738 2.330 2.420 2.411 USD 1,779 2.17
2025-06-04 SELL -371 2.090 2.210 2.198 USD -815 2.17 Loss of -12 on sale
2025-04-23 BUY 371 1.510 1.720 1.699 USD 630 2.38
2025-04-10 SELL -2,976 1.140 1.280 1.266 USD -3,768 2.48 Profit of 3,621 on sale
2025-04-08 SELL -372 1.180 1.400 1.378 USD -513 2.51 Profit of 422 on sale
2025-04-07 SELL -371 1.310 1.370 1.364 USD -506 2.53 Profit of 431 on sale
2025-04-04 SELL -1,865 1.330 1.510 1.492 USD -2,783 2.54 Profit of 1,955 on sale
2025-04-01 BUY 16,027 1.410 1.629 1.607 USD 25,757 2.57
2025-03-31 SELL -966 1.550 1.630 1.622 USD -1,567 2.58 Profit of 924 on sale
2025-03-14 SELL -5,168 1.870 1.960 1.951 USD -10,083 2.71 Profit of 3,917 on sale
2025-03-07 SELL -646 2.010 2.080 2.073 USD -1,339 2.77 Profit of 448 on sale
2025-03-04 SELL -323 1.830 1.850 1.848 USD -597 2.80 Profit of 309 on sale
2025-02-25 BUY 646 1.790 1.920 1.907 USD 1,232 2.89
2025-02-19 SELL -323 2.000 2.130 2.117 USD -684 2.96 Profit of 273 on sale
2025-02-13 BUY 966 1.940 1.996 1.990 USD 1,923 3.04
2025-02-12 BUY 322 1.960 1.980 1.978 USD 637 3.06
2025-02-11 BUY 1,288 1.910 1.930 1.928 USD 2,483 3.08
2024-12-30 SELL -12,291 2.210 2.340 2.327 USD -28,601 3.49 Profit of 14,270 on sale
2024-11-18 SELL -5,238 2.990 3.250 3.224 USD -16,887 3.97 Profit of 3,888 on sale
2024-11-08 SELL -347 3.730 4.120 4.081 USD -1,416 4.03 Loss of -18 on sale
2024-10-21 SELL -349 4.520 4.788 4.761 USD -1,662 0.00 Loss of -1,662 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-11	BUY	756	1.605	1.535	1.542	USD 1,166	2.01
2025-12-04	BUY	7,460	1.606	1.460	1.475	USD 11,001	2.02
2025-12-02	BUY	5,640	1.400	1.310	1.319	USD 7,439	2.03
2025-11-28	BUY	376	1.440	1.350	1.359	USD 511	2.04
2025-11-26	BUY	1,128	1.400	1.320	1.328	USD 1,498	2.04
2025-11-26	BUY	1,128	1.400	1.320	1.328	USD 1,498	2.04
2025-11-25	BUY	1,880	1.490	1.310	1.328	USD 2,497	2.05
2025-11-24	BUY	376	1.260	1.215	1.220	USD 459	2.05
2025-11-20	SELL	-1,496	1.342	1.230	1.241	USD -1,857	2.06 Profit of 1,223 on sale
2025-11-19	BUY	373	1.335	1.250	1.259	USD 469	2.06
2025-11-18	BUY	2,232	1.320	1.280	1.284	USD 2,866	2.07
2025-11-17	BUY	744	1.360	1.300	1.306	USD 972	2.07
2025-11-14	BUY	373	1.400	1.245	1.261	USD 470	2.07
2025-11-12	BUY	371	1.385	1.230	1.246	USD 462	2.08
2025-11-10	BUY	370	1.400	1.320	1.328	USD 491	2.09
2025-11-06	BUY	370	1.390	1.340	1.345	USD 498	2.10
2025-11-04	BUY	370	1.535	1.400	1.413	USD 523	2.11
2025-10-30	BUY	1,860	1.545	1.475	1.482	USD 2,757	2.12
2025-10-29	BUY	742	1.460	1.560	1.550	USD 1,150	2.12
2025-10-22	SELL	-1,464	1.550	1.645	1.635	USD -2,394	2.14 Profit of 731 on sale
2025-10-20	BUY	732	1.700	1.720	1.718	USD 1,258	2.14
2025-10-17	BUY	1,825	1.620	1.673	1.668	USD 3,044	2.14
2025-10-15	BUY	2,888	1.720	1.755	1.751	USD 5,058	2.15
2025-10-03	BUY	2,604	1.610	1.640	1.637	USD 4,263	2.15
2025-10-02	BUY	371	1.610	1.699	1.690	USD 627	2.16
2025-09-30	BUY	742	1.630	1.650	1.648	USD 1,223	2.16
2025-09-26	BUY	744	1.560	1.590	1.587	USD 1,181	2.17
2025-09-25	BUY	744	1.500	1.580	1.572	USD 1,170	2.17
2025-09-18	BUY	372	1.360	1.370	1.369	USD 509	2.18
2025-09-17	BUY	1,119	1.270	1.350	1.342	USD 1,502	2.18
2025-07-17	SELL	-724	2.420	2.469	2.464	USD -1,784	2.19 Loss of -202 on sale
2025-07-11	SELL	-2,920	2.470	2.520	2.515	USD -7,344	2.18 Loss of -988 on sale
2025-07-02	BUY	20,075	2.350	2.440	2.431	USD 48,802	2.17
2025-06-25	BUY	728	2.320	2.320	2.320	USD 1,689	2.17
2025-06-11	BUY	738	2.240	2.370	2.357	USD 1,739	2.17
2025-06-10	BUY	738	2.330	2.420	2.411	USD 1,779	2.17
2025-06-04	SELL	-371	2.090	2.210	2.198	USD -815	2.17 Loss of -12 on sale
2025-04-23	BUY	371	1.510	1.720	1.699	USD 630	2.38
2025-04-10	SELL	-2,976	1.140	1.280	1.266	USD -3,768	2.48 Profit of 3,621 on sale
2025-04-08	SELL	-372	1.180	1.400	1.378	USD -513	2.51 Profit of 422 on sale
2025-04-07	SELL	-371	1.310	1.370	1.364	USD -506	2.53 Profit of 431 on sale
2025-04-04	SELL	-1,865	1.330	1.510	1.492	USD -2,783	2.54 Profit of 1,955 on sale
2025-04-01	BUY	16,027	1.410	1.629	1.607	USD 25,757	2.57
2025-03-31	SELL	-966	1.550	1.630	1.622	USD -1,567	2.58 Profit of 924 on sale
2025-03-14	SELL	-5,168	1.870	1.960	1.951	USD -10,083	2.71 Profit of 3,917 on sale
2025-03-07	SELL	-646	2.010	2.080	2.073	USD -1,339	2.77 Profit of 448 on sale
2025-03-04	SELL	-323	1.830	1.850	1.848	USD -597	2.80 Profit of 309 on sale
2025-02-25	BUY	646	1.790	1.920	1.907	USD 1,232	2.89
2025-02-19	SELL	-323	2.000	2.130	2.117	USD -684	2.96 Profit of 273 on sale
2025-02-13	BUY	966	1.940	1.996	1.990	USD 1,923	3.04
2025-02-12	BUY	322	1.960	1.980	1.978	USD 637	3.06
2025-02-11	BUY	1,288	1.910	1.930	1.928	USD 2,483	3.08
2024-12-30	SELL	-12,291	2.210	2.340	2.327	USD -28,601	3.49 Profit of 14,270 on sale
2024-11-18	SELL	-5,238	2.990	3.250	3.224	USD -16,887	3.97 Profit of 3,888 on sale
2024-11-08	SELL	-347	3.730	4.120	4.081	USD -1,416	4.03 Loss of -18 on sale
2024-10-21	SELL	-349	4.520	4.788	4.761	USD -1,662	0.00 Loss of -1,662 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of AUTL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	326,083	0	1,943,029	16.8%
2025-09-18	382,849	0	2,825,877	13.5%
2025-09-17	516,772	0	1,563,009	33.1%
2025-09-16	880,380	0	3,583,123	24.6%
2025-09-15	961,514	0	2,356,872	40.8%
2025-09-12	1,507,041	0	2,625,201	57.4%
2025-09-11	656,677	0	3,996,030	16.4%
2025-09-10	508,103	0	1,107,121	45.9%
2025-09-09	777,805	0	7,543,051	10.3%
2025-09-08	301,808	0	702,550	43.0%
2025-09-05	815,104	0	5,547,519	14.7%
2025-09-04	212,805	0	524,315	40.6%
2025-09-03	982,305	3,300	4,650,376	21.1%
2025-09-02	743,883	0	4,764,447	15.6%
2025-08-29	514,960	0	909,861	56.6%
2025-08-28	634,559	0	1,135,147	55.9%
2025-08-27	203,864	0	477,156	42.7%
2025-08-26	361,467	0	1,538,089	23.5%
2025-08-25	315,607	0	1,010,986	31.2%
2025-08-22	173,517	0	689,308	25.2%
2025-08-21	236,834	0	1,399,672	16.9%
2025-08-20	251,253	9,413	1,250,783	20.1%
2025-08-19	345,863	4,501	1,494,240	23.1%
2025-08-18	219,252	11,795	2,069,610	10.6%
2025-08-15	521,924	11,077	8,500,078	6.1%
2025-08-14	429,202	18,217	1,267,384	33.9%
2025-08-13	814,215	46,900	2,001,047	40.7%
2025-08-12	1,056,283	174,254	2,049,583	51.5%
2025-08-11	819,955	11,002	1,761,401	46.6%
2025-08-08	265,227	904	489,104	54.2%
2025-08-07	334,572	483	743,135	45.0%
2025-08-06	273,013	1,038	918,637	29.7%
2025-08-05	331,882	421	1,141,216	29.1%
2025-08-04	161,974	1,861	1,212,143	13.4%
2025-08-01	312,105	600	931,499	33.5%
2025-07-31	390,125	226	1,674,571	23.3%
2025-07-30	519,108	400	936,506	55.4%
2025-07-29	562,056	5,309	1,189,224	47.3%
2025-07-28	416,097	0	901,353	46.2%
2025-07-25	251,855	2,400	707,730	35.6%
2025-07-24	342,396	2,839	1,291,463	26.5%
2025-07-23	321,734	0	659,583	48.8%
2025-07-22	236,145	2,274	721,227	32.7%
2025-07-21	221,481	684	748,574	29.6%
2025-07-18	110,879	3,304	876,030	12.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE